News
Sarepta’s stock sank after studies of Duchenne muscular dystrophy treatments failed their primary endpoints.
Seeking Alpha’s Disclaimer: The earnings call insights are compilations of…
The software company is boosting its outlook, and its CEO…
The Bank of England on Thursday lowered its interest rates for the second time this…
Danish shipping and logistics giant A.P. Moeller-Maersk and Japanese auto giant Toyota each sounded the…
Shares of Dutch Bros Inc. were flat after hours on Wednesday after the drive-through coffee…
TORM beats top-line estimates; narrows FY25 outlook
Carvana Co. late Wednesday set an ambitious long-term goal for itself and reported quarterly earnings…
Anheuser-Busch InBev reports mixed Q1 results; reaffirms FY25 outlook

